Shattuck Labs Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$3.77

+0.20 (+5.60%)

As of Feb 8, 2:02 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 10 77%

Hold 3 23%

Sell 0 0%

Price Target

Analyst Price Target +1,203.4% upside

Low Target $35.75

Average Target $49.14

High Target $66.29

Current Price $3.77

Current
$3.77

Target
$49.14

$35.75 $49.14 avg $66.29

Scenario Analysis

Bear Case

$35.75

848.3%

Low target

Base Case

$49.14

+1,203.4%

Avg target

Bull Case

$66.29

+1,658.4%

High target

Risk/Reward

2.0x

Balanced

Price in Context

52-Week High

$53.59

-93.0% from high

52-Week Low

$32.71

+-88.5% from low

Target vs 52W High

$49.14

-8.3% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%